Asset Allocation

As of December 31, 2025.
Type % Net
Cash -2.71%
Stock 93.48%
Bond 6.09%
Convertible 0.00%
Preferred 1.48%
Other 1.65%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 40.99%
Mid 42.38%
Small 16.62%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.60%    % Emerging Markets: 3.11%    % Unidentified Markets: -2.71%

Americas 14.11%
12.43%
Canada 4.26%
United States 8.17%
1.68%
Mexico 1.68%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 65.09%
United Kingdom 13.01%
52.08%
Denmark 3.77%
Finland 6.68%
France 8.51%
Germany 8.75%
Italy 6.61%
Netherlands 5.78%
Norway 2.45%
Spain 1.17%
Sweden 4.21%
Switzerland 4.15%
0.00%
0.00%
Greater Asia 23.50%
Japan 13.64%
3.13%
Australia 3.13%
5.31%
Hong Kong 2.72%
Singapore 0.83%
South Korea 1.75%
1.43%
Indonesia 1.43%
Unidentified Region -2.71%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
41.00%
Materials
9.22%
Consumer Discretionary
4.24%
Financials
26.17%
Real Estate
1.37%
Sensitive
35.28%
Communication Services
0.00%
Energy
4.67%
Industrials
20.55%
Information Technology
10.07%
Defensive
13.76%
Consumer Staples
1.82%
Health Care
4.16%
Utilities
7.79%
Not Classified
9.95%
Non Classified Equity
0.00%
Not Classified - Non Equity
9.95%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 100.0%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial